Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
9 Meters Biopharma
9 Meters Biopharma
(NMTR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Larazotide
healthy volunteers/patients
,
celiac disease
Bevifimod
factor vii deficiency
,
healthy volunteers/patients
,
alpha 1-antitrypsin deficiency
,
pneumonia
,
inflammation
,
covid-19
,
kidney transplantation
,
hemophilia a
,
hemophilia b
,
graft vs host disease
,
hereditary angioedemas
,
angioedema
,
hereditary angioedema types i and ii
,
immunologic deficiency syndromes
,
primary immunodeficiency diseases
,
infections
,
communicable diseases
,
hemorrhage
,
thromboembolism
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
sinusitis
,
pneumococcal infections
,
otitis media
,
streptococcal infections
,
bacterial pneumonia
,
meningitis
,
bacterial meningitis
,
haemophilus influenzae
,
hereditary complement deficiency diseases
,
neisseriaceae infections
,
lung diseases
,
ataxia
,
ataxia telangiectasia
,
telangiectasis
,
x-linked combined immunodeficiency diseases
,
cerebellar ataxia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use